VIDEO: FARETINA-DME study continues to shed light on faricimab treatment in DME
Click Here to Manage Email Alerts
SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Durga Borkar, MD, MMCi, discusses the FARETINA-DME study investigating real-world outcomes of faricimab treatment in diabetic macular edema.
Data were collected from the IRIS Registry and included patients with DME who were treated with at least one faricimab injection between February and September 2022.
Borkar highlights the observed improvements in visual acuity and the extension of treatment intervals.
“FARETINA-DME is the largest ongoing real-world data study of diabetic macular edema patients utilizing faricimab,” Borkar said. “We are excited to see further durability results as this data set continues to mature.”
Collapse
Borkar D. Early treatment patterns and outcomes in patients with diabetic macular edema treated with faricimab: FARETINA-DME study. Presented at: American Society of Retina Specialists annual meeting; July 28-Aug. 1, 2023; Seattle.
Read more about
Click Here to Manage Email Alerts